Vivus says FMC rejects compromise offer

July 17 (Reuters) - Obesity drug maker Vivus Inc said activist investor First Manhattan Co rejected a settlement offer by the company that included equal representation of Vivus and FMC on the board.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.